Major indices finish lower amid GE earnings disappointment >>> READ MORE

10 Hottest Small-Cap Stocks of 2012

Biotechs make up most of this high-flying crowd

      View All  

#2: Threshold Pharmaceuticals

YTD Performance: +490%

Yeah, yeah … more biotechs. Makes you wonder why you haven’t been investing more in the health care sector, doesn’t it?

Anyway, Threshold Pharmaceuticals (NASDAQ:THLD) has logged a stunning 490% jump so far in 2012. This is yet another company chasing a cancer cure, with focuses on blood cancers and bone marrow cancer like leukemia. These conditions have very few treatments available, and that’s why you see so many biotech companies racing to develop an effective medication. In addition to helping patients who have no alternatives, the first company to develop a blockbuster cure will also be rolling in dough as a result.

The company is not without risk, since despite great results from a February study we saw shares take a sharp leg down in September after data on another round of tests wasn’t as favorable … however, these biotechs are bound to be volatile since they live and die based on clinical results.

Article printed from InvestorPlace Media,

©2017 InvestorPlace Media, LLC